Health Canada approves drug that slows progression of Alzheimer’s disease | Unpublished
Hello!
Source Feed: The Globe and Mail
Author: Kelly Grant
Publication Date: October 26, 2025 - 21:08

Health Canada approves drug that slows progression of Alzheimer’s disease

October 26, 2025

Health Canada has for the first time approved a disease-modifying drug for Alzheimer’s disease, a watershed moment that offers hope for patients but does not guarantee that the complex and expensive intravenous therapy will be widely available in this country.

The federal regulator on Friday granted a conditional authorization for lecanemab, an antibody drug that can slow the progression of the disease for some people with mild cognitive impairment or early-stage dementia owing to Alzheimer’s.



Unpublished Newswire

 
The Community Services Committee today approved closing out the City’s Integrated Transition to Housing Strategy (ITHS) and address long-term initiatives through the refreshed 10-year Housing and Homelessness Plan, which will be presented to Council in Q1 2026.    Since the ITHS was developed in 2023, City efforts have addressed the exceptional demand of single adults seeking shelter and transitional housing. The City has since closed all Physical Distancing-Emergency Overflow Centres (PD-EOCs). This was made possible by:  Increasing permanent system capacity by...
October 28, 2025 - 12:58 | City of Ottawa - Media Relations / Ville d'Ottawa - Relations avec les médias | City of Ottawa News Releases
On Tuesday morning, Housing Minister Rob Flack and Finance Minister Peter Bethlenfalvy announced the move, confirming a policy which had, at times, appeared in flux.
October 28, 2025 - 12:55 | Isaac Callan | Global News - Ottawa
Health Minister Josie Osborne said the province is focused on supporting doctors and other health care professionals during a time of mounting pressure.
October 28, 2025 - 12:43 | Victoria Femia | Global News - Canada